IPO Listed — 07 Jan 2026
Listing Price: ₹90
Modern Diagnostic & Research Centre SME IPO GMP History | Listing Price ₹90 & Kostak Rate
Modern Diagnostic & Research Centre SME IPO has been listed on January 7, 2026 at a listing price of ₹90, against the issue price of ₹90 — a gain of ₹0 (+0%). The GMP peaked at ₹14 on 10 January 2026 and reached a low of ₹14 on 10 January 2026. The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Modern Diagnostic & Research Centre SME IPO raised ₹0.41 Cr. Cr. through its IPO at a price band of ₹₹85 to ₹90 per share, with a lot size of 1600 shares. The IPO was open for subscription from 31 Dec 2025 to 02 Jan 2026.
Table of Contents
- Modern Diagnostic & Research Centre SME IPO GMP Today
- Modern Diagnostic & Research Centre SME IPO GMP Trend History
- Modern Diagnostic & Research Centre SME IPO Dates
- Actual Listing Price
- Is Modern Diagnostic & Research Centre SME IPO GMP Reliable?
- Kostak Rate Explained
- About Modern Diagnostic & Research Centre SME IPO
- Frequently Asked Questions
GMP Trend Chart
Day-wise GMP Trend
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| 10 Jan 2026 | ₹ 14 | 16% | ₹ 0 | ₹ 18000 | |
| 09 Jan 2026 | ₹ 14 | 16% | ₹ 0 | ₹ 18000 | |
| 06 Jan 2026 | ₹ 14 | 16% | ₹ 0 | ₹ 0 |
Modern Diagnostic & Research Centre SME IPO Dates
| Event | Date |
|---|---|
| Open Date | 31 Dec, 2025 |
| Close Date | 02 Jan, 2026 |
| Allotment Date | 05 Jan, 2026 |
| Refund Date | 06 Jan, 2026 |
| Credit to Demat | 06 Jan, 2026 |
| Listing Date | 07 Jan, 2026 |
Modern Diagnostic & Research Centre SME IPO Actual Listing Price
| Basis | Value |
|---|---|
| Issue Price | ₹90 |
| Actual Listing Price | ₹90 (+0%) |
| Listing Gain / Loss | +₹0 per share |
| Listing Date | 07 Jan, 2026 |
Is Modern Diagnostic & Research Centre SME IPO GMP Reliable?
Grey market premium for Modern Diagnostic & Research Centre SME IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- Cross-check before acting: Review the Modern Diagnostic & Research Centre SME IPO full review for a fundamentals-based assessment before making any grey market trades.
Modern Diagnostic & Research Centre SME IPO IPO Kostak Rate Explained
The Kostak rate for Modern Diagnostic & Research Centre SME IPO was not active during the subscription period, as no grey market premium was established. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was Retail: ₹18000, SHNI: ₹, BHNI: ₹. Unlike Kostak, Subject to Sauda only applies if you receive allotment.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Modern Diagnostic & Research Centre SME IPO
The company offers a wide range of services including pathology testing, radiology services such as X-ray, ultrasound, and other specialised diagnostic solutions. Its business model is centred around operating diagnostic centres and laboratories, generating revenue through test-based services and partnerships with hospitals and clinics. With a focus on customer trust, affordability, and expansion into new locations, the company continues to strengthen its footprint in the healthcare diagnostics sector.
Frequently Asked Questions about Modern Diagnostic & Research Centre SME IPO
What is the GMP of Modern Diagnostic & Research Centre SME IPO?
The current Grey Market Premium (GMP) of Modern Diagnostic & Research Centre SME IPO is ₹ 14.
What is the Kostak Price of Modern Diagnostic & Research Centre SME IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Modern Diagnostic & Research Centre SME IPO is : Retail: ₹ 0, SHNI: ₹ 0, BHNI: ₹ 0.
What is the Subject to Sauda Price of Modern Diagnostic & Research Centre SME IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is : Retail: ₹ 18000, SHNI: ₹ 0, BHNI: ₹ 0.
What was the actual listing price of Modern Diagnostic & Research Centre SME IPO?
Modern Diagnostic & Research Centre SME IPO listed on January 7, 2026 at ₹90, against the issue price of ₹90 — a gain of +0%.
How did the GMP of Modern Diagnostic & Research Centre SME IPO trend before listing?
The GMP of Modern Diagnostic & Research Centre SME IPO was stable in its final days before listing. The GMP peaked at ₹14 on 10 January 2026. View the day-wise table above for the complete GMP history.
Explore Modern Diagnostic & Research Centre SME IPO Further
For a complete picture before making your investment decision, explore these resources:
Discussion 0
No comments yet
Be the first to share your thoughts!